Maxwell Biosciences

Austin, TX · Founded 2016 · Privately Held (backing)

Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. Maxwell Biosciences is based in Austin, TX and was founded in 2016. It was valued at $50.9 million at its seed round in Oct 2023, the last priced event on record. It has raised $35.5 million across 1 recorded round; the latest was a $10.9 million early-stage round in Oct 2021.

PMV mark · valuation
$50.9M
Oct 2026
Priced at
its seed round
Oct 2023
Total raised
$35.5M
Last round
Early Stage VC
Oct 2021

Who backs Maxwell Biosciences?

30 investors
InvestorType
U.S. Department of EnergyOther
Capital FactoryOther
National Institutes of HealthOther
Keiretsu ForumOther
Endless Frontier Labs—
Transform Investments—
Denniston Family OfficeFamily office
Das & Co.Family office
Joseph VenturesFamily office
3Rodeo—
+ 20 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Maxwell Biosciences investors

30 investors are on record for Maxwell Biosciences, including U.S. Department of Energy, Capital Factory, National Institutes of Health and Keiretsu Forum. The early-stage round in Oct 2021 drew 96 investors.

Free account
More of Maxwell Biosciences with a free account
  • ·The complete investor list: 30 names
  • ·Watch Maxwell Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like Maxwell Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View